TABLE 1.

Treatment Summary

Group	Schedule*	# Patients	Peptides†	Dose (mg)	# Vaccinations Received‡
1	qw × 4, q7w × 2	5	Class I	1	4, 4, 16, 8, 4
2	q3w × 4	7	Class I	1	2, 4, 4, 8, 2, 4, 4
3	qd × 4, q3w × 4	7	Class I	1	8, 2, 4, 3, 2, 4, 2
4	q3w × 4	12§¶	Both	1 + 4	8, 2, 4, 6, 4, 2, 2, 2, 2, 4
5	q3w × 4	6§	Class II	4	8, 2, 2, 4, 2

^*Schedule per course of treatment.

^†Class I peptide, ESO-1:165V; class II peptide, ESO-1:161-180.

^‡One vaccination is defined as one peptide injection, except for the daily-times-four schedule, where four consecutive daily peptide injections make up one vaccination.

^§One patient was censored from final immunologic analysis for having received only one vaccination.

^¶One patient was censored from final immunologic analysis because of incorrect HLA-A2 subtype.